Publications
-
MicroRNA-302 increases reprogramming efficiency via repression of NR2F2.
Hu S,
Wilson KD, Ghosh Z, Han L, Wang Y, Lan F, Ransohoff KJ, Burridge P, Wu JC.
Stem Cells.
2013;
31
(2):
259-68
-
In vivo functional and transcriptional profiling of bone marrow stem cells after transplantation into ischemic myocardium.
Sheikh AY,
Huber BC, Narsinh KH, Spin JM, van der Bogt K, de Almeida PE, Ransohoff KJ, Kraft DL, Fajardo G, Ardigo D, Ransohoff J, Bernstein D, Fischbein MP, Robbins RC, Wu JC.
Arterioscler Thromb Vasc Biol.
2012;
32
(1):
92-102
-
Advances in cardiovascular molecular imaging for tracking stem cell therapy.
Ransohoff KJ,
Wu JC.
Thromb Haemost.
2010;
104
(1):
13-22
-
Micro-CT for characterization of murine CV disease models.
Sheikh AY,
van der Bogt KE, Doyle TC, Sheikh MK, Ransohoff KJ, Ali ZA, Palmer OP, Robbins RC, Fischbein MP, Wu JC.
JACC Cardiovasc Imaging.
2010;
3
(7):
783-5
-
Poor functional recovery after transplantation of diabetic bone marrow stem cells in ischemic myocardium.
Govaert JA,
Swijnenburg RJ, Schrepfer S, Xie X, van der Bogt KE, Hoyt G, Stein W, Ransohoff KJ, Robbins RC, Wu JC.
J Heart Lung Transplant.
2009;
28
(11):
1158-1165.e1
-
Comparison of different adult stem cell types for treatment of myocardial ischemia.
van der Bogt KE,
Sheikh AY, Schrepfer S, Hoyt G, Cao F, Ransohoff KJ, Swijnenburg RJ, Pearl J, Lee A, Fischbein M, Contag CH, Robbins RC, Wu JC.
Circulation.
2008;
118
(14 Suppl):
S121-9
-
Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts.
Swijnenburg RJ,
Schrepfer S, Govaert JA, Cao F, Ransohoff K, Sheikh AY, Haddad M, Connolly AJ, Davis MM, Robbins RC, Wu JC.
Proc Natl Acad Sci U S A.
2008;
105
(35):
12991-6
Help